Obesity is associated with impaired human coronary endothelial function

Obesity Research and Clinical Practice

Volumn 3, Issue 1, 2009, Pages 9-15

  Worthley, Matthew I ^a,b   Curtis, Michael J ^a   Goodhart, David M ^a   Anderson, Todd J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Atherosclerosis; Endothelial function; Nitric oxide; Obesity

Indexed keywords

ACETYLCHOLINE; ADENOSINE; GLYCERYL TRINITRATE;

ADULT; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DOPPLER FLOWMETRY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INTRACORONARY INFUSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 60649112837     PISSN: 1871403X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.orcp.2008.09.003     Document Type: Article

References (40)

1. World Health Organization. Obesity: preventing and managing the global epidemic [WHO Technical report series No. 894]; 2000. Geneva.
2. Poirier P., Giles T.D., Bray G.A., Hong Y., Stern J.S., Pi-Sunyer F.X., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113 6 (2006) 898-918
3. Yusuf S., Hawken S., Ounpuu S., Bautista L., Franzosi M.G., Commerford P., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 9497 (2005) 1640-1649
4. Kenchaiah S., Evans J.C., Levy D., Wilson P.W., Benjamin E.J., Larson M.G., et al. Obesity and the risk of heart failure. N Engl J Med 347 5 (2002) 305-313
5. Stamler R., Stamler J., Riedlinger W.F., Algera G., and Roberts R.H. Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA 240 15 (1978) 1607-1610
6. Amad K.H., Brennan J.C., and Alexander J.K. The cardiac pathology of chronic exogenous obesity. Circulation 32 5 (1965) 740-745
7. Shinton R., Shipley M., and Rose G. Overweight and stroke in the Whitehall study. J Epidemiol Community Health 45 2 (1991) 138-142
8. Gami A.S., Hodge D.O., Herges R.M., Olson E.J., Nykodym J., Kara T., et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49 5 (2007) 565-571
9. Heitzer T., Schlinzig T., Krohn K., Meinertz T., and Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104 22 (2001) 2673-2678
10. Yeboah J., Crouse J.R., Hsu F.C., Burke G.L., and Herrington D.M. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 115 18 (2007) 2390-2397
11. Halcox J.P., Schenke W.H., Zalos G., Mincemoyer R., Prasad A., Waclawiw M.A., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106 6 (2002) 653-658
12. Schachinger V., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101 16 (2000) 1899-1906
13. Suwaidi J.A., Hamasaki S., Higano S.T., Nishimura R.A., Holmes Jr. D.R., and Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101 9 (2000) 948-954
14. von Mering G.O., Arant C.B., Wessel T.R., McGorray S.P., Bairey Merz C.N., Sharaf B.L., et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109 6 (2004) 722-725
15. Verma S., Buchanan M.R., and Anderson T.J. Endothelial function testing as a biomarker of vascular disease. Circulation 108 17 (2003) 2054-2059
16. Cox D.A., Vita J.A., Treasure C.B., Fish R.D., Alexander R.W., Ganz P., et al. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation 80 3 (1989) 458-465
17. Panza J.A., Quyyumi A.A., Brush Jr. J.E., and Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323 1 (1990) 22-27
18. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 8828 (1992) 1111-1115
19. Nitenberg A., Valensi P., Sachs R., Dali M., Aptecar E., and Attali J.R. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42 7 (1993) 1017-1025
20. Arcaro G., Zamboni M., Rossi L., Turcato E., Covi G., Armellini F., et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord 23 9 (1999) 936-942
21. Sivitz W.I., Wayson S.M., Bayless M.L., Sinkey C.A., and Haynes W.G. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction Arterial dysfunction in obesity and diabetes. J Diabetes Complications 21 3 (2007) 149-157
22. Anderson T.J., Worthley M.I., Goodhart D.M., and Curtis M.J. Relation of Basal coronary nitric oxide activity to the burden of atherosclerosis. Am J Cardiol 95 10 (2005) 1170-1174
23. Worthley M.I., Kanani R.S., Sun Y.H., Sun Y.C., Goodhart D.M., Curtis M.J., et al. Effects of tetrahydrobiopterin on coronary vascular reactivity in atherosclerotic human coronary arteries. Cardiovasc Res 76 3 (2007) 539-546
24. Goodhart D.M., and Anderson T.J. Role of nitric oxide in coronary arterial vasomotion and the influence of coronary atherosclerosis and its risks. Am J Cardiol 82 9 (1998) 1034-1039
25. Doucette J.W., Corl P.D., Payne H.M., Flynn A.E., Goto M., Nassi M., et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 85 5 (1992) 1899-1911
26. Anderson T.J., Gerhard M.D., Meredith I.T., Charbonneau F., Delagrange D., Creager M.A., et al. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol 75 (1995) 71B-74B
27. Anderson T.J., Uehata A., Gerhard M.D., Meredith I.T., Knab S., Delagrange D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26 5 (1995) 1235-1241
28. Al Suwaidi J., Higano S.T., Holmes Jr. D.R., Lennon R., and Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 37 6 (2001) 1523-1528
29. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 1 (2003) 76-79
30. Kip K.E., Marroquin O.C., Kelley D.E., Johnson B.D., Kelsey S.F., Shaw L.J., et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 109 6 (2004) 706-713
31. Willoughby S.R., Stewart S., Holmes A.S., Chirkov Y.Y., and Horowitz J.D. Platelet nitric oxide responsiveness: a novel prognostic marker in acute coronary syndromes. Arterioscler Thromb Vasc Biol 25 12 (2005) 2661-2666
32. Abdulla J., Kober L., Abildstrom S.Z., Christensen E., James W.P., and Torp-Pedersen C. Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries. Eur Heart J 29 5 (2008) 594-601
33. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 9491 (2005) 1059-1062
34. Kim J.A., Montagnani M., Koh K.K., and Quon M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113 15 (2006) 1888-1904
35. Dekker J.M., Girman C., Rhodes T., Nijpels G., Stehouwer C.D., Bouter L.M., et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn study. Circulation 112 5 (2005) 666-673
36. Bottcher M., Botker H.E., Sonne H., Nielsen T.T., and Czernin J. Endothelium-dependent and -independent perfusion reserve and the effect of l-arginine on myocardial perfusion in patients with syndrome X. Circulation 99 14 (1999) 1795-1801
37. Wohrle J., Nusser T., Merkle N., Kestler H.A., Grebe O.C., Marx N., et al. Myocardial perfusion reserve in cardiovascular magnetic resonance: correlation to coronary microvascular dysfunction. J Cardiovasc Magn Reson 8 6 (2006) 781-787
38. Knudson J.D., Dincer U.D., Zhang C., Swafford Jr. A.N., Koshida R., Picchi A., et al. Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol 289 1 (2005) H48-56
39. Ouchi N., Ohishi M., Kihara S., Funahashi T., Nakamura T., Nagaretani H., et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 42 3 (2003) 231-234
40. Takano H., Kodama Y., Kitta Y., Nakamura T., Obata J.E., Mende A., et al. Transcardiac adiponectin gradient is independently related to endothelial vasomotor function in large and resistance coronary arteries in humans. Am J Physiol Heart Circ Physiol 291 6 (2006) H2641-H2646